In head and neck cancers, binding of c-Myc to several binding sites (E-boxes) in the FAM57A transcriptional promoter was reported, raising the possibility that the FAM57A gene is a target for activation by the c-Myc oncoprotein [38]. This evidence concerns the gene MYC and head and neck cancer.